Literature DB >> 24972682

Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes.

Wen Yan1, David Polidori, Lynn Yieh, Jianing Di, Xiaodong Wu, Veronica Moreno, Lina Li, Celia P Briscoe, Nigel Shankley, G Lynis Dohm, Walter J Pories.   

Abstract

Changes in gastrointestinal peptide release may play an important role in improving glucose control and reducing body weight following Roux-en-Y gastric bypass (RYGB), but the impact of low caloric intake on gut peptide release post-surgery has not been well characterized. The purpose of this study was to assess the relationships between low caloric intake and gut peptide release and how they were altered by RYGB. Obese females including ten normoglycemic (ON) and ten with type 2 diabetes mellitus (T2DM) (OD) were studied before, 1 week, and 3 months after RYGB. Nine lean, normoglycemic women were studied for comparison. Subjects were given three separate mixed meal challenges (MMCs; 75, 150, and 300 kcal). Plasma glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) were analyzed. Prior to surgery, only minimal increases in GLP-1 and PYY were observed in response to the MMCs. After surgery, the peak GLP-1 concentration was progressively elevated in response to increasing meal sizes. The meal sizes had a statistically significant impact on elevation of GLP-1 incremental areas under the curve (ΔAUC) in both ON and OD at 1 week and 3 months post-surgery visits (p < 0.05 for all comparisons). The PYY ∆AUC was also significantly increased in a meal size-dependent manner in both ON and OD at both post-surgery visits (p < 0.05 for all comparisons). Meal sizes as small as 75-300 kcal, which cause minimal stimulation in GLP-1 or PYY release in the subjects before RYGB, are sufficient to provide statistically significant, meal size-dependent increases in the peptides post-RYGB both acutely and after meaningful weight loss occurred.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24972682     DOI: 10.1007/s11695-014-1316-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  25 in total

Review 1.  Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

Authors:  Hutan Ashrafian; Carel W le Roux
Journal:  Physiol Behav       Date:  2009-03-20

Review 2.  Multiple regulation of peptide YY secretion in the digestive tract.

Authors:  Takenori Onaga; Romuald Zabielski; Seiyu Kato
Journal:  Peptides       Date:  2002-02       Impact factor: 3.750

Review 3.  Glucagon antagonism as a potential therapeutic target in type 2 diabetes.

Authors:  J I Bagger; F K Knop; J J Holst; T Vilsbøll
Journal:  Diabetes Obes Metab       Date:  2011-11       Impact factor: 6.577

4.  Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes.

Authors:  R Lugari; C Dell'Anna; D Ugolotti; A Dei Cas; A L Barilli; R Zandomeneghi; B Marani; M Iotti; A Orlandini; A Gnudi
Journal:  Horm Metab Res       Date:  2000-10       Impact factor: 2.936

5.  Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

Authors:  Melissa A Reed; Walter J Pories; William Chapman; John Pender; Rita Bowden; Hisham Barakat; Timothy P Gavin; Tom Green; Ed Tapscott; Donghai Zheng; Nigel Shankley; Lynn Yieh; David Polidori; Steven P Piccoli; Leona Brenner-Gati; G Lynis Dohm
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

6.  Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.

Authors:  Kusal Wickremesekera; Geoff Miller; Tissa Desilva Naotunne; Graham Knowles; Richard S Stubbs
Journal:  Obes Surg       Date:  2005-04       Impact factor: 4.129

7.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

Authors:  Loredana Farilla; Angela Bulotta; Boaz Hirshberg; Sergio Li Calzi; Nasif Khoury; Houtan Noushmehr; Cristina Bertolotto; Umberto Di Mario; David M Harlan; Riccardo Perfetti
Journal:  Endocrinology       Date:  2003-08-28       Impact factor: 4.736

8.  Inhibition of food intake in obese subjects by peptide YY3-36.

Authors:  Rachel L Batterham; Mark A Cohen; Sandra M Ellis; Carel W Le Roux; Dominic J Withers; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 9.  Changes in gut hormones after bariatric surgery.

Authors:  R P Vincent; C W le Roux
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-20       Impact factor: 3.478

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

View more
  11 in total

Review 1.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms.

Authors:  Sean Manning; Andrea Pucci; Rachel L Batterham
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

2.  Variability of Length of Small Intestine in Indian Population and Its Correlation with Type 2 Diabetes Mellitus and Obesity.

Authors:  Anup Purandare; Deepak Phalgune; Shashank Shah
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

3.  The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats.

Authors:  Alonso Camacho-Ramírez; J Arturo Prada-Oliveira; Antonio Ribelles-García; David Almorza-Gomar; Gonzalo M Pérez-Arana
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Taste-related reward is associated with weight loss following bariatric surgery.

Authors:  Kimberly R Smith; Afroditi Papantoni; Maria G Veldhuizen; Vidyulata Kamath; Civonnia Harris; Timothy H Moran; Susan Carnell; Kimberley E Steele
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 5.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 6.  A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.

Authors:  Pichamol Jirapinyo; David X Jin; Taha Qazi; Nitin Mishra; Christopher C Thompson
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

7.  Effects of Diet on Bile Acid Metabolism and Insulin Resistance in Type 2 Diabetic Rats after Roux-en-Y Gastric Bypass.

Authors:  Cheng-Xiang Shan; Nian-Cun Qiu; Miao-E Liu; Si-Luo Zha; Xin Song; Zhi-Peng Du; Wen-Sheng Rao; Dao-Zhen Jiang; Wei Zhang; Ming Qiu
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

Review 8.  Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature.

Authors:  Charalampos Lampropoulos; Theodoros Alexandrides; Stylianos Tsochatzis; Dimitrios Kehagias; Ioannis Kehagias
Journal:  Obes Surg       Date:  2021-07-25       Impact factor: 4.129

Review 9.  Gastrointestinal peptides in eating-related disorders.

Authors:  Kimberly R Smith; Timothy H Moran
Journal:  Physiol Behav       Date:  2021-05-11

10.  The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki Rats.

Authors:  Laiyuan Li; Xiaolin Wang; Liangliang Bai; Huichuan Yu; Zenghong Huang; Anpei Huang; Yanxin Luo; Jianping Wang
Journal:  J Diabetes Res       Date:  2018-02-18       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.